• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胸腔镜下交感神经切除术治疗原发性局限性多汗症后的代偿性出汗:820例病例系列

Compensatory sweating after thoracoscopic sympathectomy for primary focal hyperhidrosis: a series of 820 cases.

作者信息

Santos Tiago Silva, Bachichi Thiago Gangi, Joaquim Daniela Tamega, De Sousa Maria Helena, Vieira Ponte Eduardo, De Campos José Ribas Milanez, Marchi Evaldo

机构信息

Department of Medicine and Surgery, Medicine College of Jundiaí, Rua Francisco Telles, Jundiaí, São Paulo, Brazil.

Thoracic Surgery, University of São Paulo Medical School, Cerqueira César, São Paulo, Brazil.

出版信息

Interdiscip Cardiovasc Thorac Surg. 2025 Mar 5;40(3). doi: 10.1093/icvts/ivaf063.

DOI:10.1093/icvts/ivaf063
PMID:40080705
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11938352/
Abstract

OBJECTIVES

Primary hyperhidrosis is a functionally and socially limiting condition. Thoracoscopic sympathectomy is an effective treatment for hyperhidrosis. However, post-sympathectomy compensatory sweating remains a challenge in clinical practice.

METHODS

Record analysis of patients who underwent thoracoscopic sympathectomy between 2002 and 2020. Emphasis was given to demographic data, site of complaint, functional and social impairment, procedure performed, postoperative results and compensatory sweating.

RESULTS

A total of 820 patients were included (age 23.8 [7.3] years, body mass index-BMI 22.3 [3.0] kg/m2, 66.3% female). The palmoplantar (44.3%) and palmoplantar-axillary (41.6%) sites were the most affected, followed by the axillary (12.3%) and craniofacial sites (1.8%). On a 0-4 scale, functional impairment was significantly greater in the palmoplantar group (P < 0.001) and social impairment in the axillary, palmoplantar-axillary and craniofacial groups (P < 0.001). The degree of compensatory sweating after surgery was minimal in groups palmoplantar (74.9%), palmoplantar-axillary (70.4%), axillary (63.4%) and mild in the craniofacial group (66.7%). The bivariate analyses showed significant differences in the compensatory sweating variable for age, sex, BMI and site. The multiple analysis by logistic regression showed BMI, sex and the palmoplantar-axillary, axillary and craniofacial variables to be significant for compensatory sweating.

CONCLUSIONS

Thoracoscopic sympathectomy was an effective procedure for controlling primary focal hyperhidrosis, with tolerable compensatory sweating in the patients analysed in this study.

摘要

目的

原发性多汗症是一种在功能和社交方面具有限制的病症。胸腔镜交感神经切除术是治疗多汗症的有效方法。然而,交感神经切除术后的代偿性出汗在临床实践中仍然是一个挑战。

方法

对2002年至2020年间接受胸腔镜交感神经切除术的患者进行记录分析。重点关注人口统计学数据、主诉部位、功能和社交障碍、所实施的手术、术后结果以及代偿性出汗情况。

结果

共纳入820例患者(年龄23.8[7.3]岁,体重指数-BMI为22.3[3.0]kg/m²,女性占66.3%)。手掌足底(44.3%)和手掌足底-腋窝(41.6%)部位受影响最为严重,其次是腋窝(12.3%)和颅面部部位(1.8%)。在0至4分的量表上,手掌足底组的功能障碍明显更大(P<0.001),腋窝、手掌足底-腋窝和颅面部组的社交障碍明显更大(P<0.001)。手掌足底组(74.9%)、手掌足底-腋窝组(70.4%)、腋窝组(63.4%)术后代偿性出汗程度最小,颅面部组(66.7%)为轻度。双变量分析显示,年龄、性别、BMI和部位在代偿性出汗变量方面存在显著差异。逻辑回归的多因素分析显示,BMI、性别以及手掌足底-腋窝、腋窝和颅面部变量对代偿性出汗具有显著意义。

结论

胸腔镜交感神经切除术是控制原发性局灶性多汗症的有效方法,在本研究分析的患者中代偿性出汗可耐受。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdfc/11938352/503750e6a5a1/ivaf063f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdfc/11938352/da47435c302c/ivaf063f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdfc/11938352/503750e6a5a1/ivaf063f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdfc/11938352/da47435c302c/ivaf063f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdfc/11938352/503750e6a5a1/ivaf063f1.jpg

相似文献

1
Compensatory sweating after thoracoscopic sympathectomy for primary focal hyperhidrosis: a series of 820 cases.胸腔镜下交感神经切除术治疗原发性局限性多汗症后的代偿性出汗:820例病例系列
Interdiscip Cardiovasc Thorac Surg. 2025 Mar 5;40(3). doi: 10.1093/icvts/ivaf063.
2
Comparison of only T3 and T3-T4 sympathectomy for axillary hyperhidrosis regarding treatment effect and compensatory sweating.仅T3交感神经切除术与T3-T4交感神经切除术治疗腋窝多汗症的疗效及代偿性出汗比较。
Interact Cardiovasc Thorac Surg. 2013 Aug;17(2):263-7. doi: 10.1093/icvts/ivt160. Epub 2013 May 3.
3
Thoracoscopic sympathectomy for palmar and axillary hyperhidrosis: four-year outcome and quality of life after bilateral 5-mm dual port approach.胸腔镜交感神经切除术治疗手掌和腋窝多汗症:双侧5毫米双孔入路术后四年的疗效及生活质量
Surg Endosc. 2009 Jul;23(7):1587-93. doi: 10.1007/s00464-009-0392-8. Epub 2009 Mar 4.
4
Two-stage unilateral versus one-stage bilateral single-port sympathectomy for palmar and axillary hyperhidrosis.两阶段单侧与一阶段双侧单孔交感神经切除术治疗手掌和腋窝多汗症
Interact Cardiovasc Thorac Surg. 2013 Jun;16(6):834-8. doi: 10.1093/icvts/ivt039. Epub 2013 Feb 26.
5
Long-term outcomes and predictors of compensatory sweating after bilateral endoscopic thoracic sympathectomy.双侧内镜下胸交感神经切断术后代偿性出汗的长期结局及预测因素
Eur J Cardiothorac Surg. 2025 Mar 28;67(4). doi: 10.1093/ejcts/ezaf108.
6
Plantar Sweating as an Indicator of Lower Risk of Compensatory Sweating after Thoracic Sympathectomy.足底出汗作为胸交感神经切除术后代偿性出汗风险较低的指标。
Thorac Cardiovasc Surg. 2017 Sep;65(6):479-483. doi: 10.1055/s-0036-1579680. Epub 2016 Apr 4.
7
Sympathectomy versus Sympathicotomy in Palmar Hyperhidrosis Comparing T3 Ablation.掌部多汗症中交感神经切除术与交感神经切断术对比T3消融术
Thorac Cardiovasc Surg. 2015 Dec;63(8):715-9. doi: 10.1055/s-0034-1384666. Epub 2014 Aug 1.
8
Impact of Video-Assisted Thoracoscopic Sympathectomy and Related Complications on Quality of Life According to the Level of Sympathectomy.根据交感神经切除术的水平,电视辅助胸腔镜交感神经切除术及其相关并发症对生活质量的影响。
Ann Vasc Surg. 2020 Feb;63:63-67.e1. doi: 10.1016/j.avsg.2019.07.018. Epub 2019 Oct 16.
9
Efficacy of Miniuniportal Video-Assisted Thoracoscopic Selective Sympathectomy (Ramicotomy) for the Treatment of Severe Palmar and Axillar Hyperhidrosis.迷你单孔电视辅助胸腔镜选择性交感神经切断术(分支切断术)治疗重度手掌及腋窝多汗症的疗效
Thorac Cardiovasc Surg. 2019 Aug;67(5):415-419. doi: 10.1055/s-0038-1642030. Epub 2018 May 8.
10
Bilateral thoracoscopic sympathectomy for primary hyperhydrosis: a review of 335 cases.双侧胸腔镜交感神经切除术治疗原发性多汗症:335例病例回顾
Cardiovasc J Afr. 2013 May;24(4):137-40. doi: 10.5830/CVJA-2013-007.

本文引用的文献

1
Translation and validation of Hyperhidrosis Disease Severity Scale.多汗症疾病严重程度量表的翻译与验证
Rev Assoc Med Bras (1992). 2016 Dec;62(9):843-847. doi: 10.1590/1806-9282.62.09.843.
2
Long term compensatory sweating results after sympathectomy for palmar and axillary hyperhidrosis.手掌和腋窝多汗症行交感神经切除术后会出现长期代偿性出汗。
Ann Cardiothorac Surg. 2016 Jan;5(1):26-32. doi: 10.3978/j.issn.2225-319X.2015.12.01.
3
Compensatory sweating after restricting or lowering the level of sympathectomy: a systematic review and meta-analysis.
交感神经切断术后限制或降低水平后的代偿性出汗:系统评价和荟萃分析。
Clinics (Sao Paulo). 2015 Mar;70(3):214-9. doi: 10.6061/clinics/2015(03)11. Epub 2015 Mar 1.
4
Management of hyperhidrosis.多汗症的治疗。
Clin Cosmet Investig Dermatol. 2014 Oct 29;7:285-99. doi: 10.2147/CCID.S53119. eCollection 2014.
5
Incidence and prevalence of hyperhidrosis.多汗症的发病率和患病率。
Dermatol Clin. 2014 Oct;32(4):457-65. doi: 10.1016/j.det.2014.06.006. Epub 2014 Jul 19.
6
Evaluation of anxiety and depression prevalence in patients with primary severe hyperhidrosis.原发性重度多汗症患者焦虑和抑郁患病率的评估
An Bras Dermatol. 2014 Mar-Apr;89(2):230-5. doi: 10.1590/abd1806-4841.20142189.
7
Long-term results of thoracic sympathectomy for primary hyperhidrosis.胸交感神经切除术治疗原发性多汗症的长期疗效
Pol Przegl Chir. 2013 May;85(5):247-52. doi: 10.2478/pjs-2013-0038.
8
Comparison of only T3 and T3-T4 sympathectomy for axillary hyperhidrosis regarding treatment effect and compensatory sweating.仅T3交感神经切除术与T3-T4交感神经切除术治疗腋窝多汗症的疗效及代偿性出汗比较。
Interact Cardiovasc Thorac Surg. 2013 Aug;17(2):263-7. doi: 10.1093/icvts/ivt160. Epub 2013 May 3.
9
Social anxiety and functional impairment in patients seeking surgical evaluation for hyperhidrosis.社交焦虑和功能障碍在寻求手术评估多汗症的患者中。
Compr Psychiatry. 2012 Nov;53(8):1181-6. doi: 10.1016/j.comppsych.2012.04.009. Epub 2012 Jun 7.
10
The Society of Thoracic Surgeons expert consensus for the surgical treatment of hyperhidrosis.胸外科医师协会多汗症手术治疗专家共识。
Ann Thorac Surg. 2011 May;91(5):1642-8. doi: 10.1016/j.athoracsur.2011.01.105.